Skip to content
The Waco

New study links GLP-1 ingredient to decrease in asthma attacks, COPD flare-ups

A new study has linked a GLP-1 ingredient to nearly 40 percent fewer asthma attacks. According to the study, semaglutide, which is in both Ozempic and Wegovy is a medication that is widely used for type 2 diabetes and weight loss. Research presented at the European Respiratory Society in Spain re...

Sources and story details